Delisting riskPopularity #4,280
Artelo Biosciences (ARTL)
Develops cannabinoid and fatty-acid-binding-protein drug candidates for cancer supportive care and pain.
$4.39
After hours+0.21 (+5.15%)
At close$4.18(+1.83%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 3.36% | 13.0K shares | |
|---|---|---|---|
| 10 holders · as of Jun 30, 2026 | |||
| Other | 96.64% | 374.3K shares | |
| remainder | |||
387.3K company shares as of Sep 1, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
10 holders · 117.1K shares · 5 new positions · 7 increased · 0 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Jane Street Group, LLC | 66.3K | 17.13% | +53.3K | Aug 14, 2026 |
| Geode Capital Management, LLC | 13.9K | 3.58% | +13.9Knew | Aug 12, 2026 |
| Stonex Group Inc. | 12.4K | 3.20% | +12.4Knew | Aug 12, 2026 |
| Vanguard Capital Management LLC | 10.1K | 2.62% | 0 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 8.4K | 2.18% | +5.6K | Aug 11, 2026 |
| Vanguard Fiduciary Trust Co | 3.1K | 0.81% | 0 | Aug 13, 2026 |
| UBS Group AG | 2.8K | 0.72% | +2.8Knew | Aug 13, 2026 |
| Rothschild Investment LLC | 2 | 0.00% | 0 | Aug 6, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 13G | May 15, 2026 | |
| Mitchell P. Kopin | 9.99% | 13G | Apr 3, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.
